ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
LB Pharmaceuticals Inc

LB Pharmaceuticals Inc (LBRX)

32.95
-0.79
(-2.34%)
終了 7月12日 5:00AM
32.95
0.00
(0.00%)
取引時間後: 8:59AM

LB Pharmaceuticals Inc (LBRX) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
32.95
( -2.34% )
買値
29.84
売値
36.47
出来高
186,570
平均取引量 (3 か月)
US$ 264,342
財務取引量
US$ 6,083,931
31.97 日の範囲 34.205
13.36 52 週間の範囲 35.345
時価総額
企業価値
596.494M
前日終値
33.74
始値
33.74
時刻
5
@
33.6
最終取引時間
VWAP
32.6094
歳入
-
純利益
-38.95M
発行済株式数
28,676,652
浮動株比率 (%)
63.12%
機関投資家保有比率 (%)
107.99%
配当利回り
PER
-12.89
株価売上高倍率 (PSR)
-
1 株当たり利益 (EPS)
-2.59
ベータ
-

LB Pharmaceuticals Inc について

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute... LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York. 詳細を表示

セクター
Health Care
業界
-
ウェブサイト
本社
New York, United States
設立
2026
LB Pharmaceuticals Inc is listed in the Health Care sector of the ナスダック市場 with ticker LBRX. The last closing price for LB Pharmaceuticals was US$33.74. Over the last year, LB Pharmaceuticals shares have traded in a share price range of US$ 13.36 to US$ 35.345.

LB Pharmaceuticals currently has 28,676,652 shares in issue. The market capitalisation of LB Pharmaceuticals is US$944.90 million. LB Pharmaceuticals has a price to earnings ratio (PE ratio) of -12.89.

LBRX 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.78-2.312481470533.7335.34531.84129711333.97671948CS
44.3815.330766538328.5735.34527.3738702831.56873218CS
124.1714.48922863128.7835.34526.3724231430.73083165CS
2611.7755.571293673321.1835.34518.4324768627.21990272CS
5216.1195.665083135416.8435.34513.3624652923.87372957CS
15616.1195.665083135416.8435.34513.3624652923.87372957CS
26016.1195.665083135416.8435.34513.3624652923.87372957CS

LBRX - Frequently Asked Questions (FAQ)

What is the current LB Pharmaceuticals Inc share price?
The current share price of LB Pharmaceuticals Inc is US$ 32.95
How many LB Pharmaceuticals Inc shares are in issue?
LB Pharmaceuticals Inc has 28,676,652 shares in issue
What is the market cap of LB Pharmaceuticals Inc?
The market capitalisation of LB Pharmaceuticals Inc is USD 944.9M
What is the 1 year trading range for LB Pharmaceuticals Inc share price?
LB Pharmaceuticals Inc has traded in the range of US$ 13.36 to US$ 35.345 during the past year
What is the PE ratio of LB Pharmaceuticals Inc?
The price to earnings ratio of LB Pharmaceuticals Inc is -12.89
What is the registered address of LB Pharmaceuticals Inc?
The registered address for LB Pharmaceuticals Inc is One Pennsylvania Plaza, New York, New York, 10119
What is the LB Pharmaceuticals Inc website address?
The website address for LB Pharmaceuticals Inc is lbpharma.us

LBRX 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード